Massively Parallel Sequencing of 43 Arrhythmia Genes in a Selected SUDI Cohort from Cape Town

Abstract

Sudden unexpected death in infants (SUDI) is a devastating event, and unfortunately occurs frequently in developing countries. The emerging molecular autopsy has added value to post-mortem investigations, where genetic variants were able to explain the unexpected demise. Many of these variants have been found in genes involved in arrythmia pathways. The aim of this study was to sequence 43 genes previously associated with cardiac arrhythmia in a selected cohort of SUDI cases (n = 19) in South Africa. A total of 335 variants were found among the 19 infants, of which four were novel. The variants were classified as “likely pathogenic” (n = 1), “variant of unknown significance” (n = 54), “likely benign” (n = 56) or “benign” (n = 224). The likely pathogenic variant was LMNA NM_170707.2:c.1279C > T (p.Arg427Cys) and was found in a 3-week-old male infant of African ancestry. Variants in LMNA have previously been associated with dilated cardiomyopathy, with a typical age of onset in adulthood; therefore, this may be the first report in an infant. The yield of pathogenic or likely pathogenic variants in the classic genes typically associated with channelopathies and sudden death, was less in this study compared with other settings. This finding highlights the importance of population-specific research to develop a molecular autopsy which is locally relevant.

Keywords

molecular autopsy - SIDS - sudden unexpected death in infants - LMNA - South Africa - MiSeq

Publikationsverlauf

Eingereicht: 23. Juli 2020

Angenommen: 08. Februar 2021

Artikel online veröffentlicht:
14. April 2021

• References

• 1 Roth GA, Huffman MD, Moran AE. et al. Global and regional patterns in cardiovascular mortality from 1990 to 2013. Circulation 2015; 132 (17) 1667-1678
• 2 Mente A, de Koning L, Shannon HS, Anand SS. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169 (07) 659-669
• 3 Jenkins KJ, Correa A, Feinstein JA. et al; American Heart Association Council on Cardiovascular Disease in the Young. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115 (23) 2995-3014
• 4 Wilde AAM, Behr ER. Genetic testing for inherited cardiac disease. Nat Rev Cardiol 2013; 10 (10) 571-583
• 5 Corrado D, Basso C, Judge DP. Arrhythmogenic cardiomyopathy. Circ Res 2017; 121 (07) 784-802
• 6 Baruteau A-E, Tester DJ, Kapplinger JD, Ackerman MJ, Behr ER. Sudden infant death syndrome and inherited cardiac conditions. Nat Rev Cardiol 2017; 14 (12) 715-726
• 7 Ahmed I, Nuri MM-H, Khan Orekzai MA. Hiba-tul-Waheed. Brugada syndrome: an electrical storm without warning. J Coll Physicians Surg Pak 2015; 25 (Suppl. 01) S6-S7
• 8 South African Government. The National Health Act No 61 of 2003. Vol 469;2004:1–94. Publicly Accessed November 2019 at: https://www.gov.za/documents/national-health-act#
• 9 Krous HF, Beckwith JB, Byard RW. et al. Sudden infant death syndrome and unclassified sudden infant deaths: a definitional and diagnostic approach. Pediatrics 2004; 114 (01) 234-238
• 10 Campuzano O, Sanchez-Molero O, Fernandez A, Iglesias A, Brugada R. Sudden cardiac death of arrhythmic origin: value of post-mortem genetic analysis. Spanish J Leg Med 2018; 44 (01) 32-37
• 11 McKenna WJ, Maron BJ, Thiene G. Classification, epidemiology, and global burden of cardiomyopathies. Circ Res 2017; 121 (07) 722-730
• 12 Sarquella-Brugada G, Campuzano O, Cesar S. et al. Sudden infant death syndrome caused by cardiac arrhythmias: only a matter of genes encoding ion channels?. Int J Legal Med 2016; 130 (02) 415-420
• 13 Care M, Chauhan V, Spears D. Genetic testing in inherited heart diseases: practical considerations for clinicians. Curr Cardiol Rep 2017; 19 (09) 88
• 14 Heathfield LJ, Martin LJ, Ramesar R. A systematic review of molecular autopsy studies in sudden infant death cases. J Pediatr Genet 2018; 7 (04) 143-149
• 15 Evans A, Bagnall RD, Duflou J, Semsarian C. Postmortem review and genetic analysis in sudden infant death syndrome: an 11-year review. Hum Pathol 2013; 44 (09) 1730-1736
• 16 Wang D, Shah KR, Um SY. et al. Cardiac channelopathy testing in 274 ethnically diverse sudden unexplained deaths. Forensic Sci Int 2014; 237: 90-99
• 17 Doolan A, Langlois N, Chiu C, Ingles J, Lind JM, Semsarian C. Postmortem molecular analysis of KCNQ1 and SCN5A genes in sudden unexplained death in young Australians. Int J Cardiol 2008; 127 (01) 138-141
• 18 Glengarry JM, Crawford J, Morrow PL, Stables SR, Love DR, Skinner JR. Long QT molecular autopsy in sudden infant death syndrome. Arch Dis Child 2014; 99 (07) 635-640
• 19 Heathfield LJ, Martin LJ, Ramesar R. A 5-year retrospective analysis of infant death at Salt River Mortuary, Cape Town. South African J Child Heal 2020; 14 (03) 148
• 20 Department of Justice. South Africa. The Inquests Act 58 of 1959. South Africa: . Accessed November 2019 at: http://www.justice.gov.za/legislation/acts/1959–58.pdf 1959
• 21 QIAGEN. QIAamp^® DNA Investigator Sample & Assay Technologies. 2012;June:1–60. Publicly Accessed November 2019 at: https://www.qiagen.com/us/resources/resourcedetail?id=26ef8f2c-7c2a-49e6-b2d2-39d4e130b3cc&lang=en
• 22 Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet Journal 2011; 17 (01) 10-12
• 23 Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 2009; 25 (14) 1754-1760
• 24 Li H, Handsaker B, Wysoker A. et al; 1000 Genome Project Data Processing Subgroup. The sequence alignment/map format and SAMtools. Bioinformatics 2009; 25 (16) 2078-2079
• 25 Rimmer A, Phan H, Mathieson I. et al; WGS500 Consortium. Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications. Nat Genet 2014; 46 (08) 912-918
• 26 Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res 2010; 38 (16) e164-e164
• 27 Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PEM. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat 2008; 29 (01) 6-13
• 28 Kopanos C, Tsiolkas V, Kouris A. et al. VarSome: the human genomic variant search engine. Bioinformatics 2019; 35 (11) 1978-1980
• 29 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 30 Odendaal HJ, Elliott A, Kinney HC. et al; Prenatal Alcohol and SIDS and Stillbirth (PASS) Network. Consent for autopsy research for unexpected death in early life. Obstet Gynecol 2011; 117 (01) 167-171
• 31 Modell SM, Lehmann MH. The long QT syndrome family of cardiac ion channelopathies: a HuGE review. Genet Med 2006; 8 (03) 143-155
• 32 Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 2001; 104 (22) 2746-2753
• 33 Filonzi L, Magnani C, Lavezzi AM. et al. Association of dopamine transporter and monoamine oxidase molecular polymorphisms with sudden infant death syndrome and stillbirth: new insights into the serotonin hypothesis. Neurogenetics 2009; 10 (01) 65-72
• 34 Hershberger RE, Morales A. LMNA-related dilated cardiomyopathy. GeneReviews, updated 7 July 2016. Publicly Accessed November 2019 at: https://www.ncbi.nlm.nih.gov/books/NBK1674/
• 35 Brayson D, Shanahan CM. Current insights into LMNA cardiomyopathies: existing models and missing LINCs. Nucleus 2017; 8 (01) 17-33
• 36 Captur G, Arbustini E, Bonne G. et al. Lamin and the heart. Heart 2018; 104 (06) 468-479
• 37 Bertrand AT, Chikhaoui K, Yaou RB, Bonne G. Clinical and genetic heterogeneity in laminopathies. Biochem Soc Trans 2011; 39 (06) 1687-1692
• 38 Ben Yaou R, Toutain A, Arimura T. et al. Multitissular involvement in a family with LMNA and EMD mutations: Role of digenic mechanism?. Neurology 2007; 68 (22) 1883-1894
• 39 Methner DNR, Scherer SE, Welch K. et al. Postmortem genetic screening for the identification, verification, and reporting of genetic variants contributing to the sudden death of the young. Genome Res 2016; 26 (09) 1170-1177
• 40 Ishikawa T, Takahashi N, Ohno S. et al. Novel SCN3B mutation associated with Brugada syndrome affects intracellular trafficking and function of Nav1.5. Circ J 2013; 77 (04) 959-967
• 41 Mohler PJ, Yoon W, Bennett V. Ankyrin-B targets β2-spectrin to an intracellular compartment in neonatal cardiomyocytes. J Biol Chem 2004; 279 (38) 40185-40193
• 42 Cunha SR, Le Scouarnec S, Schott J-J, Mohler PJ. Exon organization and novel alternative splicing of the human ANK2 gene: implications for cardiac function and human cardiac disease. J Mol Cell Cardiol 2008; 45 (06) 724-734
• 43 Amin AS, Meregalli PG, Bardai A, Wilde AAM, Tan HL. Fever increases the risk for cardiac arrest in the Brugada syndrome. Ann Intern Med 2008; 149 (03) 216-218
• 44 Filiano JJ, Kinney HC. A perspective on neuropathologic findings in victims of the sudden infant death syndrome: the triple-risk model. Biol Neonate 1994; 65 (3-4): 194-197
• 45 Opdal SH, Rognum TO, Vege A, Stave AK, Dupuy BM, Egeland T. Increased number of substitutions in the D-loop of mitochondrial DNA in the sudden infant death syndrome. Acta Paediatr 1998; 87 (10) 1039-1044
• 46 Rueda M, Wagner JL, Phillips TC. et al. Molecular autopsy for sudden death in the young: is data aggregation the key?. Front Cardiovasc Med 2017; 4: 72